
Avalo Therapeutics (AVTX) Market Capitalization Overview
Market Cap: $307.38M as of Jan 9, 2026
$307.38M
$54.41M (15.04%)past month
As of Jan 9, 2026, Avalo Therapeutics (AVTX) has a market capitalization of $307.38M. Over the past 30 days, its market cap has increased by 1.43%, while in the last 12 months, it has decreased by -6.66%.
Market capitalization represents the total value of Avalo Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Avalo Therapeutics (AVTX) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Avalo Therapeutics (AVTX) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Avalo Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Avalo Therapeutics (AVTX) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Avalo Therapeutics (AVTX) helps investors assess the company's size and compare it with competitors for better investment decisions.
Avalo Therapeutics (AVTX) Market Cap & Key Trends
See Avalo Therapeutics’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Avalo Therapeutics (AVTX)
Order type
Buy in
Order amount
Est. shares
0 shares
Avalo Therapeutics (AVTX) Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 1, 2025 | $304.29M | +38.79% |
| Nov 3, 2025 | $219.26M | +28.63% |
| Oct 1, 2025 | $170.46M | +43.68% |
| Sep 2, 2025 | $118.64M | +38.87% |
| Aug 1, 2025 | $85.43M | +63.02% |
| Jul 1, 2025 | $52.41M | +11.26% |
| Jun 2, 2025 | $47.11M | -12.43% |
| May 1, 2025 | $53.79M | -26.42% |
| Apr 1, 2025 | $73.11M | +4.27% |
| Mar 3, 2025 | $70.11M | -16.46% |
| Feb 3, 2025 | $83.92M | -4.86% |
| Jan 2, 2025 | $88.21M | -14.42% |
Avalo Therapeutics (AVTX) End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $307.38M | -6.66% |
| 2025 | $329.32M | +323.58% |
| 2024 | $77.75M | +965.80% |
| 2023 | $7.30M | -84.63% |
| 2022 | $47.45M | -75.26% |
| 2021 | $191.76M | — |
FAQs About Avalo Therapeutics (AVTX) Market Cap
As of Jan 9, 2026, the market capitalization of Avalo Therapeutics (AVTX) is $307.38M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Avalo Therapeutics’s market capitalization has decreased by -15.04%, changing from $361.78M to $307.38M as of Jan 9, 2026.
In the last 3 months, Avalo Therapeutics’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Avalo Therapeutics’s market capitalization increased from $77.75M in January to $329.32M in December, reflecting a 323.58% change.
In the past five years, Avalo Therapeutics (AVTX) has had a compound annual growth rate (CAGR) of 11.42% in market capitalization. This means its market cap has grown at an average rate of 11.42% per year.